Stock IdeasZen Rating Upgrades & DowngradesZen Rating Upgrades & DowngradesBe the first to know when a stock's Zen Rating gets upgraded or downgraded.
Stock IdeasZen Rating Upgrades & Downgrades
| Name / Ticker | Date | Price | Market Cap | Old Zen Rating | New Zen Rating | Upgrade/Downgrade |
|---|---|---|---|---|---|---|
Magna International IncMGA | 2026-01-12 | $56.45 | $15.91B | B | A | Upgrade |
Neurocrine Biosciences IncNBIX | 2026-01-12 | $132.66 | $13.16B | B | A | Upgrade |
Mirum Pharmaceuticals IncMIRM | 2026-01-12 | $89.50 | $4.50B | B | A | Upgrade |
Upgrade to Premium to View More
Upgrade to Premium to view the rest of today's Zen Ratings Upgrades / Downgrades. Stocks that are Zen-Rated “A” have an average return of +32.52%. Learn more.
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.